These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL; Antúnez MI; Abrami AA Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [TBL] [Abstract][Full Text] [Related]
3. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798 [TBL] [Abstract][Full Text] [Related]
4. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Muñoz-Fernández MA; Fernández MA; Fresno M Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373 [TBL] [Abstract][Full Text] [Related]
5. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Hertz CJ; Mansfield JM Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343 [TBL] [Abstract][Full Text] [Related]
6. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260 [TBL] [Abstract][Full Text] [Related]
7. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931 [TBL] [Abstract][Full Text] [Related]
8. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. Uzonna JE; Kaushik RS; Gordon JR; Tabel H J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527 [TBL] [Abstract][Full Text] [Related]
9. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. Abrahamsohn IA; Coffman RL J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103 [TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. Shibata Y; Foster LA; Kurimoto M; Okamura H; Nakamura RM; Kawajiri K; Justice JP; Van Scott MR; Myrvik QN; Metzger WJ J Immunol; 1998 Oct; 161(8):4283-8. PubMed ID: 9780204 [TBL] [Abstract][Full Text] [Related]
11. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection]. Laucella SA; Rottenberg ME; de Titto EH Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488 [TBL] [Abstract][Full Text] [Related]
12. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472 [TBL] [Abstract][Full Text] [Related]
13. Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells. Eksi S; Wassom DL; Powell MR J Parasitol; 1996 Feb; 82(1):59-65. PubMed ID: 8627502 [TBL] [Abstract][Full Text] [Related]
14. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. Hoft DF; Lynch RG; Kirchhoff LV J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708 [TBL] [Abstract][Full Text] [Related]
16. Parasite antigen-induced IFN-gamma and IL-4 production by cells from pathopermissive and pathoresistant strains of mice infected with Trypanosoma cruzi. Humphrey JS; McCormick TS; Rowland EC J Parasitol; 1997 Jun; 83(3):533-6. PubMed ID: 9194843 [TBL] [Abstract][Full Text] [Related]
17. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Zhang L; Tarleton RL Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051 [TBL] [Abstract][Full Text] [Related]
18. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710 [TBL] [Abstract][Full Text] [Related]
19. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249 [TBL] [Abstract][Full Text] [Related]
20. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. Namangala B; Noël W; De Baetselier P; Brys L; Beschin A J Infect Dis; 2001 Jun; 183(12):1794-800. PubMed ID: 11372033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]